Ticker LaunchReverse merger · Completed
Ayala Pharmaceuticals, Inc.
Reverse merger with Advaxis, Inc. (ADXS)
Ayala Pharmaceuticals, Inc. merged into Advaxis, Inc. (ADXS), a OTC-traded biotech seeking merger, in a reverse merger that takes the private company public. The deal was announced on Oct 19, 2022 and closed on Jan 19, 2023. The combined company trades as Ayala Pharmaceuticals, Inc..
- Status
- Completed
- Private company
- Ayala Pharmaceuticals, Inc.
- Public company
- Advaxis, Inc. (ADXS)
- Public company business before
- OTC-traded biotech seeking merger
- Announced
- Oct 19, 2022
- Closed
- Jan 19, 2023
- Combined company
- Ayala Pharmaceuticals, Inc.
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K Jan 25, 2023
- Announcement 8-K Oct 19, 2022
- Announcement exhibit
- All filings on EDGAR CIK 1797336
Other completed reverse mergers
- Cycle Energy Corp.into American International Holdings Corp. · Feb 15, 2023
- Lithium Harvest ApSinto Sustainable Projects Group Inc. · Feb 15, 2023
- International CuMo Mining Corporationinto Joway Health Industries Group Inc. · Jan 23, 2023
- Pineapple Consolidated, Inc.into Minaro Corp. · Jan 19, 2023
- Business with Friends, Inc.into Kashin, Inc. · Jan 19, 2023
- Cambell International Holding Limitedinto Bitmis Corp. · Dec 30, 2022